227 related articles for article (PubMed ID: 9433388)
1. Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system.
Ward ME; Woodhouse A; Mather LE; Farr SJ; Okikawa JK; Lloyd P; Schuster JA; Rubsamen RM
Clin Pharmacol Ther; 1997 Dec; 62(6):596-609. PubMed ID: 9433388
[TBL] [Abstract][Full Text] [Related]
2. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
3. Does intraosseous equal intravenous? A pharmacokinetic study.
Von Hoff DD; Kuhn JG; Burris HA; Miller LJ
Am J Emerg Med; 2008 Jan; 26(1):31-8. PubMed ID: 18082778
[TBL] [Abstract][Full Text] [Related]
4. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
Kharasch ED; Hoffer C; Whittington D; Sheffels P
Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
6. Disposition and miotic effects of oral alfentanil: a potential noninvasive probe for first-pass cytochrome P4503A activity.
Kharasch ED; Hoffer C; Walker A; Sheffels P
Clin Pharmacol Ther; 2003 Mar; 73(3):199-208. PubMed ID: 12621385
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
Foster D; Upton R; Christrup L; Popper L
Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
[TBL] [Abstract][Full Text] [Related]
8. Arterial and venous pharmacokinetics of intravenous heroin in subjects who are addicted to narcotics.
Rentsch KM; Kullak-Ublick GA; Reichel C; Meier PJ; Fattinger K
Clin Pharmacol Ther; 2001 Sep; 70(3):237-46. PubMed ID: 11557911
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics and bioavailability of prochlorperazine delivered as a thermally generated aerosol in a single breath to volunteers.
Avram MJ; Spyker DA; Henthorn TK; Cassella JV
Clin Pharmacol Ther; 2009 Jan; 85(1):71-7. PubMed ID: 18830225
[TBL] [Abstract][Full Text] [Related]
10. Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans.
Huupponen R; Karhuvaara S; Anttila M; Vuorilehto L; Scheinin H
Clin Pharmacol Ther; 1995 Nov; 58(5):506-11. PubMed ID: 7586944
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
Dohoo SE; Tasker RA
Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
[TBL] [Abstract][Full Text] [Related]
12. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
14. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R
Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs.
Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG
J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of intramuscularly administered morphine in horses.
Devine EP; KuKanich B; Beard WL
J Am Vet Med Assoc; 2013 Jul; 243(1):105-12. PubMed ID: 23786198
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and physiological effects of two intravenous infusion rates of morphine in conscious dogs.
Guedes AG; Papich MG; Rude EP; Rider MA
J Vet Pharmacol Ther; 2007 Jun; 30(3):224-33. PubMed ID: 17472654
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts.
Girardin F; Rentsch KM; Schwab MA; Maggiorini M; Pauli-Magnus C; Kullak-Ublick GA; Meier PJ; Fattinger K
Clin Pharmacol Ther; 2003 Oct; 74(4):341-52. PubMed ID: 14534521
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
